Cresset Asset Management, LLC Clovis Oncology, Inc. Transaction History

Cresset Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.7 - $4.76 $49,590 - $87,426	-18,367 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $5,659 - $8,085	1,394 Added 8.21%	18,367 $82,000
Q2 2021 Aug 10, 2021	BUY	$5.02 - $7.05 $23,393 - $32,853	4,660 Added 37.85%	16,973 $98,000
Q1 2021 May 12, 2021	BUY	$4.81 - $10.34 $59,225 - $127,316	12,313 New	12,313 $87,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.